ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2134

Responsiveness and Predictive Ability Of The Knee Society Scale (KSS) Score

Jasvinder A. Singh1,2, Cathy Schleck3, W. Scott Harmsen4 and David Lewallen5, 1Rheumatology, Birmingham VA, Birmingham, AL, 2Department of Medicine, University of Alabama, Tuscaloosa, AL, 3Mayo Clinic College of Medicine, Rochester, MN, 4Mayo Clinic, Rochester, MN, 5Orthopedics, Mayo Clinic college of medicine, Rochester, MN

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Joint replacement, Knee, outcome measures and patient outcomes, Validity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects II: Symptoms and Therapeutics in Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose: The KSS questionnaire has previously been shown to have face, content and construct validity and test-retest reliability. Our objective was to assess the Responsiveness and Predictive Ability of the KSS.

Methods: We used data from the Mayo Clinic Total Joint Registry to assess the validity of KSS questionnaire, by including patients who underwent primary total knee arthroplasty (TKA) between 1993-2005 and responded to the baseline and 2-year post-primary TKA KSS questionnaire.  KSS questionnaire generates three domain scores: KSS function score (walking, stairs and use of knee supports), range of motion and KSS score (pain, range of motion and stability) scores. Convergent/divergent validity was examined with the association of select demographics (age, gender, number of joints involved) at baseline with KSS scores using linear regression and correlation analyses.  Responsiveness was assessed with Minimally Clinically Important Difference (MCID) and Really Important Difference (RID) were calculated corresponding to “somewhat better now” and “much better now” patient responses, respectively to the question at 2-years- Compared to your condition before the surgery, how would you rate your knee now?  For discriminant ability, we calculated effect size by taking the change in respective score from baseline to 2-years and dividing the result by the standard deviation at baseline. Predictive ability was assessed by association of improvement in KSS function (categorized as <=10, 11-40 and >40) and KSS scores at 2-years (minus preoperative scores; categorized as <= 35, 36-63, and 64-95) with revision surgery at time after 2-years. 

Results: For primary TKA, there were 5,280 knees with both a baseline and a 2-year data. The sample consisted of 2,375 males (45%) and 2,905 females (55%). The mean age at surgery (SD) is 68 (10), median age was 70 (range, 17-93).  

MCID and RID thresholds were as follows: KSS function score, 7.0 and 29.3; KSS score, 27.7 and 51.0; range of motion, 11.7 and 20.4.  Respective effect sizes at 2-years were large, 1.37 for function score, 2.60 for knee score and 1.56 for range of motion; and consistent with effect sizes for other validated scales for arthroplasty. 

Improvement in KSS-function score was associated significantly with the risk of revision after 2-years (Table 1); total KSS score showed a trend towards significant association (p=0.07)

Conclusion: KSS and KSS-function scores are responsive in patients undergoing primary TKA. KSS scores can predict the risk of early revision after primary TKA.  These findings imply that a regular monitoring of patient-reported outcomes of pain and function may allow signal detection for early TKA revision.

Table 1. Predictive ability of KSS score for revision TKA

 

Hazard ratio (95% CI)

p-value

Improvement in KSS-function (n=4270 with 179 events)

 

 

<= 10 vs. 41-100

1.87 (1.23,2.83)

0.003

11-40 vs.41-100

1.18 (0.78,1.78)

0.43

Improvement in KSS (n=785 with 13 events*)

 

 

<= 35 vs. 64-95

16.63 (2.07,2150)

0.07

36-63 vs. 64-95

4.95 (0.56,658)

0.31

*186 TKAs did not have data to calculate KSS scores


Disclosure:

J. A. Singh,

Takeda, Savient,

2,

Savient, Takeda, Ardea, Regeneron, Allergan,

5,

URL pharmaceuicals Novartis,

5;

C. Schleck,
None;

W. S. Harmsen,
None;

D. Lewallen,

DePuy, Stryker, Biomet and Zimmer.,

2,

Zimmer, Orthosonic and Osteotech,

7,

Pipeline,

5,

Pipeline,

1.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/responsiveness-and-predictive-ability-of-the-knee-society-scale-kss-score/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology